Brought to you by:

Cell & Gene Therapy

Graphic image of a red thumbs down against a blue background
Biotech

FDA rejects Capricor’s DMD cell therapy, asks for more data

The rejection raises questions about whether the new-look FDA leadership may be rowing back from some of the flexibility shown by the old regime.
Nick Paul Taylor Jul 11, 2025 9:18am
reshuffle pipeline target reorganize shift change

AstraZeneca’s Alexion pens $825M AAV capsid pact with JCR

Jul 9, 2025 4:52am
KJ Muldoon graduates from the hospital and heads home for the first time

Center launches with $20M to create CRISPR therapies for kids

Jul 8, 2025 11:59am
Cargo shipping containers lost in ocean

Concentra extends biotech shopping spree by collecting Cargo

Jul 8, 2025 9:28am
Human kidney anatomy

ProKidney cell therapy wins half of trial, falls short on other

Jul 8, 2025 8:00am
Horseshoe magnet attracting metallic pawn people

Biotech shares first data for in vivo CAR-T that attracted AZ

Jul 7, 2025 2:27pm
More News

CSL consolidates R&D team in shift toward external partners

Jul 7, 2025 12:44pm

4DMT lays off 25% of workforce while phase 3 timeline ramps up

Jul 3, 2025 4:52am

Oncternal sells cancer assets to mystery biotech, winds down ops

Jul 1, 2025 9:38am

AbbVie inks $2.1B Capstan buyout to enter in vivo CAR-T market

Jun 30, 2025 9:45am